TRANSGENIC GROUP INC. (2342.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

107.5x

EV/EBITDA

11.0x

Market Cap

JPY 4.11B

MomentumView details →

1D Return

−0.80%

YTD Return

−16.72%

RSI (14)

59.9

ValuationView details →

P/E (Fwd)

107.5x

EV/EBITDA

11.0x

Market Cap

JPY 4.11B

RSI (14)

59.9

MomentumView details →

1D Return

−0.80%

YTD Return

−16.72%

ProfitabilityView details →

Gross Margin

18.47%

Net Margin

−0.58%

EBITDA Margin

1.86%

ROE (TTM)

−1.59%

ROA (TTM)

−0.79%

Asset Turnover

1.31x

GrowthView details →

Revenue YoY

+1.30%

EPS YoY

+92.94%

FCF YoY

—

Revenue CAGR 3Y

+4.85%

EPS CAGR 3Y

+92.92%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

1.74x

Quick Ratio

1.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

−40.00%

Financials snapshotView financials →

Revenue (TTM)

13.17B

Net Income (TTM)

−77.00M

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

Transgenic Group reported its fiscal year ending March 2027 first-quarter (April-June) results, with recurring profit surging 2.6 times year-on-year to 150 million yen, reaching 78.0% of the full-year plan of 200 million yen.24d ago

Similar companies

IZUMI group Inc.551A.T SONOCOM CO.,LTD.7902.T AI CROSS Inc.4476.T IID,Inc.6038.T THERMAE-YU HOLDINGS CO.,LTD.3521.T CHIeru Co.,Ltd.3933.T Find similar companies →

Latest newsMore news →

Transgenic Group reported its fiscal year ending March 2027 first-quarter (April-June) results, with recurring profit surging 2.6 times year-on-year to 150 million yen, reaching 78.0% of the full-year plan of 200 million yen.24d ago